InsiderClue
Insiders · Profile

Singh Shawn

CHIEF EXECUTIVE OFFICER at Vistagen Therapeutics. Filing since 17 Aug 2022. CIK 0001412071

Company
Date
Role
Action
Shares
Amount
Of holding
VTGN Vistagen Therapeutics, Inc.
17 Aug 2022
CHIEF EXECUTIVE OFFICER
Bought
600,000
$103.20K
×23
1 decision on file.